Noradrenergic Mechanisms in Parkinson’s Disease and L-DOPA-Induced Dyskinesia: Hypothesis and Evidences from Behavioural and Biochemical Studies

QR Code

Noradrenergic Mechanisms in Parkinson’s Disease and L-DOPA-Induced Dyskinesia: Hypothesis and Evidences from Behavioural and Biochemical Studies

None

Saved in:

Bibliographic Details
Main Author:	Alachkar, Amal
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/27867
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tianqi pingchan granule promotes recovery of glymphatic system function in a rat model of l-DOPA-induced dyskinesia
by: Zhihua Liu, et al.
Published: (2025-07-01)

The Noradrenergic System is a Major Component in Parkinson’s Disease
by: Szot, Patricia, et al.
Published: (2011)

Imaging Dyskinesias in Parkinson’s Disease
by: Politis, Marios, et al.
Published: (2011)

Oxidative DNA Damage and the Level of Biothiols, and L-Dopa Therapy in Parkinson’s Disease
by: Jolanta, Dorszewska, et al.
Published: (2011)

Pathophysiological mechanisms underlying antipsychotic-induced tardive dyskinesia
by: E. E. Vayman, et al.
Published: (2020-01-01)

Pathophysiology of Drug-Induced Dyskinesias
by: Lieu, Christopher A., et al.
Published: (2011)

Electroconvulsive therapy for depression and oral dyskinesia in a patient who developed parkinsonism induced by valbenazine
by: Yuhei Mori, et al.
Published: (2025-06-01)

Noradrenergic excitation of astrocytes supports cognitive reserve
by: Robert Zorec, et al.
Published: (2026-04-01)

The noradrenergic paradox: implications in the management of depression and anxiety
by: Montoya A, et al.
Published: (2016-03-01)

Opportunities and Limitations of Wrist-Worn Devices for Dyskinesia Detection in Parkinson’s Disease
by: Alexander Johannes Wiederhold, et al.
Published: (2025-07-01)

l-Tyrosine and l-DOPA: Promising scaffolds for the synthesis of biologically active compounds
by: Ndayiragije, Euphrem, et al.
Published: (2024-11-01)

Probing the Mechanism of l‑DOPA 2,3-Dioxygenase Using Synthetic Derivatives of 3,4-Dihydroxyhydrocinnamic Acid
by: Amen Taye Demisew, et al.
Published: (2025-07-01)

Inefficacy of Repetitive Transcranial Magnetic Stimulation in Parkinson’s Disease Patients with Levodopa-Induced Dyskinesias: Results from a Pilot Study
by: Alma Medrano-Hernández, et al.
Published: (2025-07-01)

A REVIEW ON THE RELATIONSHIPS AMONG ADAPTIVE MARKETS HYPOTHESIS, THE EFFICIENT MARKETS HYPOTHESIS AND BEHAVIOURAL FINANCE
by: Kubra SARITEPECI, et al.
Published: (2023-12-01)

Post-stroke dyskinesias
by: Nakawah MO, et al.
Published: (2016-11-01)

Primary Ciliary Dyskinesia in Children
by: Alexander A. Baranov, et al.
Published: (2018-02-01)

Primary Ciliary Dyskinesia Registry
by: Mohammadreza Modaresi, et al.
Published: (2024-01-01)

Neuroprotective Effects of Herbal Butanol Extracts from Gynostemma pentaphyllum on the Exposure to Chronic Stress in a 6-Hydroxydopamine- Lesioned Rat Model of Parkinson's Disease Treated with or Without L-DOPA
by: Lee, Myung Koo, et al.
Published: (2012)

Candidate genes involved in the development of antipsychotic-induced tardive dyskinesia in patients with schizophrenia
by: E. E. Vaiman, et al.
Published: (2020-12-01)

Locus Coeruleus Noradrenergic‐Spinal Projections Contribute to Electroacupuncture‐Mediated Antinociception in Postoperative Pain in Mice
by: Wen‐Guang Chu, et al.
Published: (2025-07-01)

RÜLFS CRAMP AND OTHER PAROXYSMAL DYSKINESIA
by: M. V. Selikhova, et al.
Published: (2016-05-01)

Primary ciliary dyskinesia. Clinical observation
by: T. B. Pavlova, et al.
Published: (2016-02-01)

Primary ciliary dyskinesia: A review
by: Shally Awasthi, et al.
Published: (2025-01-01)

Evidence for the Vacated Niche Hypothesis in Parasites of Invasive Mammals
by: Annakate M. Schatz, et al.
Published: (2025-02-01)

FROM EFFICIENT MARKET HYPOTHESIS TO BEHAVIOURAL FINANCE: CAN BEHAVIOURAL FINANCE BE THE NEW DOMINANT MODEL FOR INVESTING?
by: George BOROVAS, et al.
Published: (2012-12-01)

Impact of Tetrahydropyrido[2,1-b][1,3,5]thiadiazines on L-DOPA Effects in the Tail Suspension Test
by: E. Yu. Bibik, et al.
Published: (2020-06-01)

Impulse Control Disorders and Other Compulsive Behaviours in Parkinson’s Disease – What Is Current Evidence of Treatment?
by: Agnieszka Gross
Published: (2025-06-01)

New Evidence of Environmental Kuznets Curve Hypothesis in Developing Countries
by: Malik Cahyadin, et al.
Published: (2021-12-01)

Possibilities of group chronophysiotherapy at gall-bladder dyskinesias
by: O. A. Poddubnaya, et al.
Published: (2012-02-01)

Science and hypothesis /
by: Poincare, H.
Published: (1952)

Modern Approaches to the Diagnosis and Management of Children With Primary Ciliary Dyskinesia
by: A. A. Baranov, et al.
Published: (2017-05-01)

Primary Ciliary Dyskinesia/Kartagener Syndrome - Clinical and Genetic Aspects
by: Akita, Masumi
Published: (2011)

The input hypothesis : issues and implications /
by: Krashen, Stephen D.
Published: (1985)

Optimization of [18F]-DOPA PET/CT Protocol in Patients with Medullary Thyroid Carcinoma: a Prospective Study
by: N. V. Tsentr, et al.
Published: (2025-03-01)

On the plate tectonics hypothesis
by: V. V. Gordienko
Published: (2013-12-01)

The linear hypothesis : a general theory /
by: Seber, G. A. F. (George Arthur Frederick), 1938-
Published: (1980)

Diagnostics and treatment of biliary dyskinesia: clinical guidelines of the Russian gastroenterological Association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Advances in Drug Therapy: Alternative Treatments for the Control of Motor Fluctuations and Dyskinesias
by: González, José Matías Arbelo, et al.
Published: (2011)

SPHINCTER OCHSNER DYSKINESIA AS A CAUSE OF SUPERIOR MESENTERIC ARTERY SYNDROME
by: M. D. Levin
Published: (2016-05-01)

Is chronic neck pain related to scapular dyskinesia? A systematic review
by: Norollah Javdaneh, et al.
Published: (2025-07-01)